Much to the chagrin of the Indian pharmaceutical industry and patients alike, fake drugs are everywhere. Successful brands are being…
India?s Rs 40,000 crore domestic pharmaceutical market is increasingly becoming the battleground between the multinational pharma majors and home-grown drug…
It seemed like a symbolic tipping point for Indian clinical trials industry when Bangalore-based Stempeutics Research recently got the Drugs…
Stem cell banks will no longer throw the umbilical cord in the wastebasket after collecting the umbilical cord blood. The…
For all those, who cherish the increasing base of IT, communication and electronic products in the country, here?s one harsh…
An interesting game of research might is being played out between India and China in the realm of biotech crops.…
The image of an operation theatre that comes to one?s mind is that of a crowded place with two to…
At LV Prasad Eye Institute, Hyderabad, eye specialists are using a new approach to repair eye damage. By growing new…
Until now, menstrual blood has typically been discarded as unsanitary waste. Few are aware that the blood shed during women?s…
Open source drug discovery initiative of Council of Scientific and Industrial Research, also known in industry circles as wiki-style of…
Quest for a ?Made in India? drug molecule is getting longer as Indian pharma majors battle declining sources of funding…
With starry dreams in their eyes, tech startups from India?s leading technical and research institutes?Indian Institutes of Technology, Indian Institute…
To say that the global drug industry is grappling with a severe crisis would be an understatement. Industry is facing…
It?s a classic case of market opportunity aplenty. The global clinical trials business is worth an estimated $50 billion at…
Indian life sciences majors are making a determined bid to tap the $32-billion stem cell therapies and research market. Can…
Indian contract research organisations are facing an identity crisis. They are struggling to restore their image as charges of illegal…
Don?t be taken in by Indian enterprises? swanky ERP and other financial solutions. Tax-related data is still confined to manual…
Potential risks of nanotech, GM foods and stem cells could outweigh the benefits to human health and the environment
